Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel, orally bioavailable compound for the treatment of migraine presented by Merck

March 23, 2009

Novel naphthalene derivatives patented by Servier

March 23, 2009

Qutenza receives positive CHMP recommendation for neuropathic pain

March 23, 2009

Valeant Pharmaceuticals International presents novel potassium channel modulators

March 23, 2009

ProteoTech reports on small molecule targeting alpha-synuclein aggregation for Parkinson's disease

March 23, 2009

GABA receptor inverse agonist shows potential in in vivo models of Alzheimer's

March 23, 2009

Novartis patents novel beta-secretase inhibitors

March 20, 2009

Tapentadol IR found safer than oxycodone IR for the treatment of pain

March 20, 2009

Small ciliary neurotrophic factor peptides designed to improve cognition

March 20, 2009

Antiepileptic drug shows efficacy in neuropathic pain

March 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...